1 completed, 1 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow KN026: new trials by email Literature Review of KN026 trials Research Report on KN026
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| KN026 in Patients With HER2 Expressing Breast Cancer and Gastric Cancer KN026 - Breast Cancer, Gastric/Gastroesophageal Junction Cancer | Phase 1 | Unknown | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 22 | 2019-06-18 | 2021-11-17 |
| Trial of KN026 in Patients With HER2-positive Advanced Malignant Breast Cancer and Gastric Cancer KN026 - Breast Cancer, Gastric Cancer | Phase 1 | Completed | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 63 | 2018-09-17 | 2024-03-12 |
Breast Neoplasms (2) · Stomach Neoplasms (1)
Jiangsu Alphamab Biopharmaceuticals Co., Ltd (2)
China (1) · United States (1)